Member Info for HereKittyKitty

Feels like the broker ratings into upcoming results are moving them both now

Means we will be bought more & get exposure into pension funds & ETFs etc incl foreign investments as safer in FTSE250

https://inews.co.uk/news/scotland/covid-scotland-nicola-sturgeon-update-new-lockdown-restrictions-cases-latest-1165298

“ Cambridge-based cybersecurity firm Darktrace is set to join the FTSE 250 just four months after listing in London.”

https://www.cityam.com/just-eat-and-itv-set-to-be-booted-from-ftse-100-while-morrisons-and-meggitt-could-be-added/

Covid infection protection waning in double jabbed

https://www.bbc.co.uk/news/health-58322882

Lots more testing building into Winter!

It’s been dropping consistently for 5 months so who wants back in?

…. And top up when they give you bargains

Might see the ADBX profit takers back here now it’s crashing down

Sorry if you’ve read already but based on:

- 50% growth
- 121% growth DHSC even with dispute
- 20% growth outside DHSC
- New contact for supply of PROmate COVID-19 tests to the NHS
- 2 year Long-Term Agreement with the World Health Organization (WHO)
- UK private market sales increased significantly
- H1 sales £94.7 million, compared to £63.3 million

And the amazing fundamentals

- Today NCYT has a 276m Market Cap @ 390 SP
- Revenue is up from 277m last FY
- Profit is up froM 167m
- Net assets 150m
- Cash is up from 92m
- Debt £0 (debt free!)

I’d value this 1170 to 1560

Weekly Covid deaths at highest since March

https://news.sky.com/story/covid-19-england-and-wales-record-highest-total-of-weekly-coronavirus-related-deaths-since-march-12389319

Patience always rewards

GOLDMAN CUTS BOOHOO PRICE TARGET TO 460 (510) PENCE - 'BUY'

UK retail sales surge in August, price pressures up too - CBI

https://www.euronews.com/2021/08/24/uk-health-coronavirus-britain-retail

You’ve got to love how corrupt the markets are here!
Undervalued company with solid fundamentals, revenue, profit, cash in bank & no debt goes down vs one with no Sales & carry debt going up 35%
Very good buy in point

Only a few weeks now until results & hopefully a good re rate based on uplifted forecast

And Let’s nots forget

- 50% growth
- 121% growth DHSC even with dispute
- 20% growth outside DHSC
- New contact for supply of PROmate COVID-19 tests to the NHS
- 2 year Long-Term Agreement with the World Health Organization (WHO)
- UK private market sales increased significantly
- H1 sales £94.7 million, compared to £63.3 million

And the amazing fundamentals

- Today NCYT has a 289m Market Cap @ 409 SP
- Revenue is up from 277m last FY
- Profit is up froM 167m
- Net assets 150m
- Cash is up from 92m
- Debt £0 (debt free!)

And who cares about DHSC now?

1) it’s factored in
2) they have new deals with NHS
3) they have 2 years with WHO
4) they are expanding rapidly in US
5) revenue, profit & cash position is solid
6) private sector growing rapidly
7) demand for tests is still increasing
8) the DHSC dispute will be resolved amicably as they are getting new NHS contracts
9) UNICEF distributing in 8 countries

And Let’s nots forget

- 50% growth
- 121% growth DHSC even with dispute
- 20% growth outside DHSC
- New contact for supply of PROmate COVID-19 tests to the NHS
- 2 year Long-Term Agreement with the World Health Organization (WHO)
- UK private market sales increased significantly
- H1 sales £94.7 million, compared to £63.3 million

And the amazing fundamentals

- Today NCYT has a 289m Market Cap @ 409 SP
- Revenue is up from 277m last FY
- Profit is up froM 167m
- Net assets 150m
- Cash is up from 92m
- Debt £0 (debt free!)

And who cares about DHSC now?

1) it’s factored in
2) they have new deals with NHS
3) they have 2 years with WHO
4) they are expanding rapidly in US
5) revenue, profit & cash position is solid
6) private sector growing rapidly
7) demand for tests is still increasing
8) the DHSC dispute will be resolved amicably as they are getting new NHS contracts
9. UNICEF distributing in 8 countries

Forget even great U.K. revenue & US growth as there is all this to!

Novacyt also entered into a two-year long-term agreement with the World Health Organization (WHO), for the supply of its 'genesig' Covid-19 tests.

In addition, the company said it had received confirmation from UNICEF that its existing long-term agreement with the organisation had been extended by 12 months, to July 2022.

To date, Novacyt had shipped orders to a total of eight countries under the UNICEF agreement since last September.

leading companies operating in the Americas COVID-19 testing market are:

Sky Medical Supplies & Equipment LLC.
Sugentech, Inc.
Novacyt Group
Aurora Instruments Ltd.
PRIMA Lab SA
SD Biosensor, INC.
Gold Standard Diagnostics
Eurofins Technologies
Biomerieux SA
Danaher